P
TMDX icon

&Partners’s Transmedics TMDX Stock Holding History

&Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$511K Sell
5,137
-1,595
-24% -$208K ﹤0.01% 1683
2025
Q4 		$819K Buy
6,732
+264
+4% +$33.1K ﹤0.01% 1331
2025
Q3 		$726K Sell
6,468
-116
-2% -$13.6K ﹤0.01% 1244
2025
Q2 		$882K Sell
6,584
-462
-7% -$50.7K 0.01% 1043
2025
Q1 		$483K Buy
+7,046
New +$485K 0.01% 1151

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

&Partners's TMDX Position: Q1 2026 in Review

&Partners reduced its Transmedics (TMDX) stake by 24% in Q1 2026, selling an estimated $208K and leaving 5,137 shares worth $511K. The position accounts for ﹤0.01% of the portfolio, ranked #1683.

&Partners first reported a position in TMDX in Q1 2025 and has held it in 5 quarters since. The position peaked at $882K in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • &Partners held 5,137 shares of Transmedics worth $511K as of Q1 2026.
  • &Partners sold 1,595 Transmedics shares in Q1 2026, an estimated $208K.
  • Transmedics made up ﹤0.01% of &Partners's portfolio in Q1 2026, its #1683 holding.
  • &Partners first reported a position in Transmedics in Q1 2025 and has held it in 5 quarters since.
  • &Partners's Transmedics position peaked at $882K in Q2 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.